Developments in Diabetes Vaccine Market 2020 – 2027| Imcys– a Belgium-based biotech company

Diabetes is one of most prevalent chronic diseases worldwide. According to WHO (World Health Organization), diabetes was one of top three leading causes of mortality in 2012. The diabetes vaccine currently under development has significant potential in younger age group (Below 20 years age), who are characterized by a stronger autoimmune response to combat infection from specific viruses.

Leave a Reply

Your email address will not be published. Required fields are marked *

Developments in Diabetes Vaccine Market 2020 – 2027| Imcys– a Belgium-based biotech company

Diabetes is one of most prevalent chronic diseases worldwide. According to WHO (World Health Organization), diabetes was one of top three leading causes of mortality in 2012. The diabetes vaccine currently under development has significant potential in younger age group (Below 20 years age), who are characterized by a stronger autoimmune response to combat infection from specific viruses.

Leave a Reply

Your email address will not be published. Required fields are marked *